Impact of metabolic syndrome components on clinical outcomes in hypertriglyceridemia-induced acute pancreatitis

doi:10.3748/wjg.v30.i35.3996

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 35

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-4) series.

Item

Count

PDF

HTML

Figures (1-5)

Tables (1-4)

Sum=0

Sep 21, 2024 (publication date) through Sep 13, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Sep 21, 2024; 30(35): 3996-4010
Published online Sep 21, 2024. doi: 10.3748/wjg.v30.i35.3996

Table 2 Impact of individual metabolic syndrome components on adverse clinical outcomes in hypertriglyceridemia-acute pancreatitis

Outcome	Obesity		Hyperglycaemia		Hypertension		Low HDL-C
Outcome	OR (95%CI)	P value	OR (95%CI)	P value	OR (95%CI)	P value	OR (95%CI)	P value
Pleural effusion	1.52 (0.89-2.61)	0.129	1.75 (0.88-3.46)	0.109	1.12 (0.69-1.84)	0.644	2.57 (1.55-4.27)	< 0.001^a
Peritoneal effusion	0.98 (0.55-1.75)	0.941	1.44 (0.67-3.11)	0.349	1.20 (0.70-2.05)	0.505	3.02 (1.70-5.36)	< 0.001^a
Localized complications	2.07 (1.07-4.00)	0.031^a	3.04 (1.53-6.06)	0.002^a	0.82 (0.47-1.42)	0.476	2.06 (1.18-3.59)	0.011^a
APFC	2.73 (1.50-4.96)	0.001^a	2.61 (0.98-6.99)	0.055	0.96 (0.54-1.71)	0.889	0.82 (0.46-1.46)	0.499
ANC	1.02 (0.59-1.79)	0.963	1.47 (0.71-3.05)	0.298	0.75 (0.45-1.25)	0.271	2.32 (1.37-3.94)	0.002^a
PPC	0.48 (0.13-1.74)	0.484	0.89 (0.24-3.24)	0.855	1.45 (0.54-3.89)	0.461	0.58 (0.21-1.58)	0.288
Systemic complications	1.81 (1.05-3.14)	0.034^a	2.86 (1.40-5.82)	0.004^a	1.81 (1.09-2.98)	0.021^a	2.38 (1.43-3.93)	0.001^a
Respiratory failure	2.16 (1.15-4.04)	0.016^a	2.08 (0.77-5.60)	0.146	1.40 (0.76-2.57)	0.276	4.94 (2.35-10.37)	< 0.001^a
Renal failure	2.06 (1.02-4.14)	0.044^a	2.56 (0.75-8.75)	0.133	0.85 (0.43-1.71)	0.654	3.40 (1.54-7.49)	0.002^a
Circulatory failure	1.08 (0.36-3.21)	0.896	3.02 (0.39-23.48)	0.292	0.55 (0.19-1.64)	0.283	2.74 (0.86-8.73)	0.089
SIRS	1.39 (0.81-2.37)	0.235	3.04 (1.53-6.06)	0.002^a	1.84 (1.12-3.03)	0.017	1.76 (1.07-2.90)	0.026^a
Sepsis	0.71 (0.22-2.25)	0.560	1.47 (0.32-6.69)	0.618	1.13 (0.42-3.02)	0.814	2.99 (0.95-9.43)	0.062
ACS	1.11 (0.43-2.84)	0.829	1.23 (0.35-4.38)	0.745	1.57 (0.65-3.78)	0.315	2.47 (0.93-6.53)	0.069
ARDS	1.92 (0.69-5.35)	0.214	1.37 (0.30-6.25)	0.688	1.28 (0.46-3.51)	0.637	4.02 (1.12-14.47)	0.033^a
MODS	1.74 (0.81-3.73)	0.156	3.18 (0.73-13.86)	0.124	0.84 (0.40-1.79)	0.654	3.54 (1.47-8.52)	0.005^a
SAP	1.85 (1.00-3.43)	0.050	1.83 (0.73-4.59)	0.201	1.17 (0.65-2.12)	0.598	4.32 (2.16-8.66)	< 0.001^a
ICU admission	1.69 (0.90-3.17)	0.102	2.14 (0.80-5.74)	0.132	1.47 (0.80-2.69)	0.211	3.91 (1.94-7.85)	< 0.001^a

^aP < 0.05.

Adjusted for age and sex. OR: Odds ratio; HDL-C: High-density lipoprotein cholesterol; APFC: Acute peripancreatic fluid collection; ANC: Acute necrotic collection; PPC: Pancreatic pseudocyst; SIRS: Systemic inflammatory response syndrome; ACS: Abdominal compartment syndrome; ARDS: Acute respiratory distress syndrome; MODS: Multiple organ dysfunction syndrome; SAP: Severe acute pancreatitis; ICU: Intensive care unit.

Citation: Fu ZH, Zhao ZY, Liang YB, Cheng DY, Luo JM, Jiang HX, Qin SY. Impact of metabolic syndrome components on clinical outcomes in hypertriglyceridemia-induced acute pancreatitis. World J Gastroenterol 2024; 30(35): 3996-4010
URL: https://www.wjgnet.com/1007-9327/full/v30/i35/3996.htm
DOI: https://dx.doi.org/10.3748/wjg.v30.i35.3996